We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Featured News

 

Latest News

Biologists Develop Genome-wide map of miRNA-mRNA Interactions
News   Mar 20, 2006

Parts of the predicted map were confirmed through the development of an in vivo method.

READ MORE

Nastech Announces Multi-Compound Agreement with Novo Nordisk
News   Mar 20, 2006

Nastech enters into agreement with respect to certain Novo Nordisk therapeutic compounds.

READ MORE

Pharmacopeia and Neurocrine Expand Drug Discovery and Development Collaboration
News   Mar 20, 2006

The companies have elected to expand the scope of their collaboration to include an additional disease target.

READ MORE

Mirus Bio Announces Genetic Immunization Method to Produce Antibodies
News   Mar 20, 2006

This research tool is available for licensing for those who wish to use it within the biotechnology and pharmaceutical industry.

READ MORE

AdipoGenix Achieves Third Milestone in Collaboration with Johnson & Johnson
News   Mar 20, 2006

The milestone was for the identification of the molecular target for one of J&J's active compounds.

READ MORE

ActivX Announces Expansion of Collaboration Agreement With Pfizer
News   Mar 20, 2006

ActivX will apply its chemical technologies and high-throughput protein analysis to a number of Pfizer programs.

READ MORE

MPT Expands BLAST Database Support to its BioTech VPC
News   Mar 20, 2006

Users of MPT’s BLAST benefit from tremendous speedup in time to answers for large BLAST jobs.

READ MORE

CTC Analytics and Agilent to Provide Integrated Autosampler Solution
News   Mar 17, 2006

CTC autosamplers will be available as original equipment for Agilent’s LC, LC/MS, GC and GC/MS products.

READ MORE

Cytomics Systems Completes € 10 Million Round of Financing
News   Mar 17, 2006

This round will enable the company to accelerate the development of its antifungal compounds.

READ MORE

Santaris Pharma Raises EUR 40 M of new Equity
News   Mar 17, 2006

The funds will enable the further development of Santaris Pharma’s platform for LNA-based human therapeutics.

READ MORE